| CEO: | Stuart Ashman |
| Executive Director: | Simon Hewitson |
| Independent Non-Executive Director: | Catherine Denise Prescott |
| Non-Executive Chairman: | Martin Braddock Hunt |
| Non-Executive Dir: | Danielle Bekker |
| Address: | The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF |
| Phone: | +44 191 495 7325 |
| Website: | http://www.skinbiotherapeutics.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BF33H870 |
| Currency | UK Pounds |
| Share Price | 14.25p |
| Change Today | 0.63p |
| % Change | 4.59 % |
| 52 Week High | 14.40 |
| 52 Week Low | 13.63 |
| Volume | 694,348 |
| Shares Issued | 258.78m |
| Market Cap | £36.88m |
| Beta | 0.54 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:20 | 17,283 @ 14.13p |
| 12:09 | 55,605 @ 14.38p |
| 11:53 | 3,442 @ 14.38p |
| 10:37 | 90 @ 13.95p |
| 10:32 | 12,447 @ 14.40p |
You are here: research